177 related articles for article (PubMed ID: 36344998)
1. Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis.
Avanceña ALV; Miller A; Canana N; Dula J; Saifodine A; Cadrinho B; Maffioli EM
Malar J; 2022 Nov; 21(1):320. PubMed ID: 36344998
[TBL] [Abstract][Full Text] [Related]
2. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
[TBL] [Abstract][Full Text] [Related]
3. Cost and cost-effectiveness of indoor residual spraying with pirimiphos-methyl in a high malaria transmission district of Mozambique with high access to standard insecticide-treated nets.
Alonso S; Chaccour CJ; Wagman J; Candrinho B; Muthoni R; Saifodine A; Saute F; Robertson M; Zulliger R
Malar J; 2021 Mar; 20(1):143. PubMed ID: 33691706
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.
Chen IT; Aung T; Thant HN; Sudhinaraset M; Kahn JG
Malar J; 2015 Feb; 14():55. PubMed ID: 25653121
[TBL] [Abstract][Full Text] [Related]
6. Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.
Niyibitegeka F; Thavorncharoensap M; Riewpaiboon A; Youngkong S
Appl Health Econ Health Policy; 2022 Sep; 20(5):707-716. PubMed ID: 35469393
[TBL] [Abstract][Full Text] [Related]
7. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysis.
Krishnan A; Finkelstein EA; Kallestrup P; Karki A; Olsen MH; Neupane D
Lancet Glob Health; 2019 Oct; 7(10):e1367-e1374. PubMed ID: 31537367
[TBL] [Abstract][Full Text] [Related]
9. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
[TBL] [Abstract][Full Text] [Related]
10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique.
Sicuri E; Bardají A; Nhampossa T; Maixenchs M; Nhacolo A; Nhalungo D; Alonso PL; Menéndez C
PLoS One; 2010 Oct; 5(10):e13407. PubMed ID: 20976217
[TBL] [Abstract][Full Text] [Related]
13. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial.
Akpan E; Hossain SJ; Devine A; Braat S; Hasan MI; Tipu SMMU; Bhuiyan MSA; Hamadani JD; Biggs BA; Pasricha SR; Carvalho N
Am J Clin Nutr; 2022 Nov; 116(5):1303-1313. PubMed ID: 36192508
[TBL] [Abstract][Full Text] [Related]
16. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
[TBL] [Abstract][Full Text] [Related]
18. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?
Zikusooka CM; McIntyre D; Barnes KI
Malar J; 2008 Sep; 7():176. PubMed ID: 18793410
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
